What's in Fundacion IDEAA's pipeline?

Fundacion IDEAA has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Fundacion IDEAA's portfolio?

Top competitors by shared drug class: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Brigham and Women's Hospital, Janssen Sciences Ireland UC, Merck Sharp & Dohme LLC, National Institute of Allergy and Infectious Diseases (NIAID).

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/fundacion-ideaa.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Fundacion IDEAA — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fundacion IDEAA pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Emtricitabine / Tenofovir Disoproxil Pill	Emtricitabine / Tenofovir Disoproxil Pill	marketed	Nucleoside/nucleotide reverse transcriptase inhibitor combination	HIV-1 reverse transcriptase	Infectious Disease / Virology

Therapeutic area mix

Infectious Disease / Virology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · 1 shared drug class
Brigham and Women's Hospital · 1 shared drug class
Janssen Sciences Ireland UC · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
National Institute of Allergy and Infectious Diseases (NIAID) · 1 shared drug class
University of Chicago · 1 shared drug class
University of Washington · 1 shared drug class
ViiV Healthcare · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fundacion IDEAA:

Cite this brief

Drug Landscape (2026). Fundacion IDEAA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fundacion-ideaa. Accessed 2026-05-17.